Company intelligence

CellCentric

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. Biotech's AI Drug Discovery Funding Keeps ClimbingAI-driven drug discovery startups keep pulling nine-figure rounds, with Basecamp Research closing an oversubscribed $140 million Series C and CellCentric raising $220 million.→

Coverage Timeline

newest first
  1. Oct 5, 2026FUNDINGBiotech's AI Drug Discovery Funding Keeps Climbing$140M-$220M rounds→

All Coverage

FUNDING

Biotech's AI Drug Discovery Funding Keeps Climbing

Illustration for: Biotech's AI Drug Discovery Funding Keeps Climbing
FUNDING$140M-$220M rounds

Biotech's AI Drug Discovery Funding Keeps Climbing

AI-driven drug discovery startups keep pulling nine-figure rounds, with Basecamp Research closing an oversubscribed $140 million Series C and CellCentric raising $220 million.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly